Savara Inc.
XNAS:SVRA
5.82
$6.75 - 100.00
$5.20 - 7.00
$5.71
$5.95
$5.91
$5.88
7.01
1.89
1652410
1579341.9
102416431.67
Chart
TendieTensor AI Analysis
Company
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
Fundamentals
59
-10.880000
10.768000
100
BBG000MS0823
BBG001SFTVM9
172.84M
201.30M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own SVRA. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.